Adding belzutifan to standard adjuvant pembrolizumab cut the risk for recurrence or death in patients with resected clear cell renal cell carcinoma. Medscape Medical News Source link : https://www.medscape.com/viewarticle/adjuvant-belzutifan-combo-practice-changing-rcc-2026a10006nc?src=rss Author...
Read more



















